Latest Strategic Refocus News

Pioneer Lithium has sharpened its focus on North American critical minerals, advancing uranium, antimony, and tungsten projects while securing $750,000 in fresh capital to fund exploration and working capital.

Linius Technologies has implemented a sweeping operational restructure, cutting expenses by more than 60% compared to FY25, while progressing a pivotal proof of concept with a major European football league and securing over $3.7 million in new funding.

Peppermint Innovation Ltd reports strong quarterly progress with new payment functionalities live, a key merchant licence granted, and a strategic pivot toward AI-driven lending.

Future Metals NL appoints Keith Bowes as CEO and initiates a strategic review of its flagship Panton project, leveraging rising platinum group metal prices and exploration successes. The company also completes a A$4.2 million capital raise and plans to delist from AIM.

Buxton Resources reports promising assay results from its maiden drilling at the Centurion Project, alongside strategic leadership changes and a solid cash position heading into 2026.

Miramar Resources has granted Future Battery Minerals an exclusive option to acquire its Randalls Project for up to A$800,000, enabling a strategic refocus on its core gold and critical minerals assets.

EROAD pivots strategically to prioritise ANZ electronic road user charging opportunities, revises FY26 guidance downward, and appoints John Scott as Executive Chair to steer growth.

Bank of Queensland reported a 4% increase in revenues to $1.668 billion for FY25, yet profits after tax fell sharply by 53% to $133 million. Despite the profit decline, the bank declared a fully franked 20 cent dividend for the full year.

Trigg Minerals is advancing its strategy to list on the U.S. NASDAQ, weighing options including a dual listing and potential SPAC mergers, while planning a name change to reflect its evolving focus.

QuickFee Limited has completed the sale of its US Pay Now business, announced a 7.5 cent per share capital return, appointed founder Bruce Coombes as CEO, and updated its FY26 earnings guidance.

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Whitebark Energy has finalized the sale of its remaining 10% interest in the Wizard Lake assets to Conflux Energy, marking a strategic shift to focus on Australian projects.